Cinven is reviewing strategic options for laboratory-services company Synlab International GmbH including a potential sale, people with knowledge of the matter said.
The private equity firm has been speaking with potential advisers and could start a sale process early next year, the people said, asking not to be identified because the information is private. Cinven plans to seek a valuation of about 5.5 billion euros ($6 billion) including debt for Augsburg, Germany-based Synlab, one of the people said.
A sale of Synlab would likely attract other private equity firms, the people said. No final decision has been made, and Cinven could elect to keep the business, the people said. A spokeswoman for Cinven declined to comment, while Synlab didn’t answer phone calls seeking comment.
Cinven first invested in Synlab in June 2015, buying a majority stake from fellow private equity firm BC Partners for about 1.7 billion euros, Bloomberg News reported at the time. It combined the business with Labco SA, which it agreed to buy earlier that year for 1.2 billion euros.
Synlab, led by Chief Executive Officer Mathieu Floreani, also counts Novo A/S and Ontario Teachers’ Pension Plan as minority investors, according to its website. It operates across more than 40 countries, handling more than 500 million clinical tests annually, according to Synlab’s website.
Cinven also owns stakes in retailer Kurt Geiger and German drugmaker Stada Arzneimittel AG, according to its website.
The sale plan comes at a time when Cinven’s rival Apax Partners is also weighing a sale of diagnostic services business Unilabs. The buyout firm is working with advisers at Rothschild & Co. to look at options for the business, people familiar with the matter said last week.
Source: Bloomberg
Can’t stop reading? Read more
Clearlake and Insight close to $2bn private credit deal for Alteryx LBO
Clearlake Capital and Insight Partners are close to agreeing a $2bn debt package with a group of private credit lenders including Apollo Global Management and Blackstone to help finance their leveraged buyout of software developer Alteryx, according to a report by...
Carlyle to launch new European private credit strategy for private wealth investors
Global private investment firm Carlyle is to launch a new semi-liquid European private credit strategy (ETAC) which provides individual investors with access to the firm’s $188bn AUM global credit platform. The new evergreen strategy provides individuals with access...
US Private Equity Giants’ Executives See $40bn Surge in Share Value Amid Record Asset Growth
The value of the shares held by the founders and top executives of some of the largest US private equity groups, including Carlyle, Blackstone, KKR, Apollo Global, and Ares Management, have risen by $40bn — the most since the beginning of last year on the back of a...




